Search Result "atherogenic index"
Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2892-2901
Author(s): S. Oravec,A. Dukat,P. Gavornik,M. Kucera,K. Gruber,L. Gaspar,M. Rizzo,P.P. Toth,D.P. Mikhailidis,M. Banach
Blood Serum Atherogenicity and Coronary Artery Calcification
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 3 Year: 2014 Page: 5884-5888
Author(s): Igor A. Sobenin, Veronica A. Myasoedova, Elena V. Anisimova, Xenia N. Pavlova, Stefan Mohlenkamp, Axel Schmermund, Rainer Seibel, Sina Berenbein, Nils Lehmann, Susanne Moebus, KarlHeinz Jockel, Alexander N. Orekhov, Raimund Erbel
Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 6 Year: 2018 Page: 589-595
Author(s): Ping Song,Lan Xu,Jin Xu,Hai-qing Zhang,Chun-xiao Yu,Qing-bo Guan,Meng Zhao,Xu Zhang
Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Journal: Current Rheumatology Reviews
Volume: 17 Issue: 1 Year: 2021 Page: 122-130
Author(s): Nevin Hammam,Noha Abdel-Wahab,Tamer A Gheita
Elevated Serum Levels of Ischemia Modified Albumin and Malondialdehyde are Related to Atherogenic Index of Plasma in a Cohort of Prediabetes
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 20 Issue: 8 Year: 2020 Page: 1347-1354
Author(s): Mervat M. El-Eshmawy,Doaa F. Gad,Azza A. El-Baiomy
The Anti-Atherogenic Effects of Thiazolidinediones
Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 67-74
Author(s): Lily Stojanovska, Suzy Y. Honisett, Paul A. Komesaroff
Blood Serum Atherogenicity: Cellular Test for the Development of Anti- Atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 8 Year: 2017 Page: 1195-1206
Author(s): Veronika A. Myasoedova,Galina A. Ivashinnikova,Igor A. Sobenin,Ekaterina A. Ivanova,Alexander N. Orekhov
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 89-102
Author(s): Julie Nigro, Mandy L. Ballinger, Narin Osman, Anthony M. Dart, Peter J. Little
Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Journal: Vascular Disease Prevention
Volume: 2 Issue: 2 Year: 2005 Page: 107-114
Author(s): Yehuda Kamari, Irit Avni, Ehud Grossman, Yehonatan Sharabi